Skip to main content
P

Precision Biosensor Inc. — Investor Relations & Filings

Ticker · 335810 ISIN · KR7335810008 KO Manufacturing
Open in API
Filings indexed 172 across all filing types
Latest filing 2021-05-17 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 335810

About Precision Biosensor Inc.

https://precision-bio.com/

Precision Biosensor Inc. is an in vitro diagnostics (IVD) company that develops, manufactures, and commercializes clinical diagnostic solutions. The company specializes in point-of-care testing (POCT), providing optimized systems for on-site diagnosis. Its product portfolio includes analyzing devices and diagnostic reagents for both human and animal health. Precision Biosensor utilizes advanced technologies, such as time-resolved fluorescence (TRF), for the sensitive and accurate detection of various disease biomarkers in immuno-diagnosis and clinical chemistry applications, including cardiac markers.

Recent filings

Filing Released Lang Actions
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for Precision Biosensor, Inc. (프리시젼바이오 주식회사) covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial information, business overviews, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-17 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting held on March 24, 2021. It includes financial statement approvals, director appointments, and voting outcomes. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2021-03-24 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options). It details the issuance of stock options to employees and executives, including the number of shares, exercise price, and valuation methodology (Black-Scholes). This type of disclosure regarding the issuance of new equity-based compensation falls under the category of share issuance or capital changes, which is best classified as 'SHA' (Share Issue/Capital Change).
2021-03-24 Korean
사업보고서 (2020.12)
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report' (감사보고서) for Precision Bio, Inc. (프리시젼바이오 주식회사) covering the fiscal years 2019 and 2020. It includes the independent auditor's report from Samjong KPMG, the financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and the accompanying notes. It is a comprehensive financial audit document, not an earnings release or a simple announcement, and fits the definition of an Audit Report (AR). FY 2020
2021-03-17 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from the Korean Exchange (KRX) system titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of financial statements, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the fiscal year. While it contains financial data, it is a standardized regulatory disclosure form used to announce the completion and submission of the audit report to the exchange, rather than the full, multi-page audit report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2020
2021-03-16 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory disclosure from a Korean company (Precision Biosensor) regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty, duration, and terms. Since this is a specific regulatory announcement of a material business event that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-03-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.